How Actigraphy is Clearing Operational Barriers to Decentralized Trials

Overview

Wearable-enabled decentralized clinical trials (DCTs) are transforming drug development by empowering patients to participate from home, reducing the burdens on participants, and expanding the opportunities to collect data. Yet, operational challenges are impeding efforts to realize those benefits. Faced with those barriers, sponsors are turning to proven systems for collecting real-world data to support their DCTs.

In this ActiGraph white paper, we cover the operational challenges of DCTs and how actigraphy is being used to clear those barriers.